Mustafa Diken

13.3k total citations · 3 hit papers
93 papers, 5.4k citations indexed

About

Mustafa Diken is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Mustafa Diken has authored 93 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Immunology, 50 papers in Molecular Biology and 30 papers in Oncology. Recurrent topics in Mustafa Diken's work include Immunotherapy and Immune Responses (61 papers), RNA Interference and Gene Delivery (35 papers) and Cancer Immunotherapy and Biomarkers (18 papers). Mustafa Diken is often cited by papers focused on Immunotherapy and Immune Responses (61 papers), RNA Interference and Gene Delivery (35 papers) and Cancer Immunotherapy and Biomarkers (18 papers). Mustafa Diken collaborates with scholars based in Germany, United States and Netherlands. Mustafa Diken's co-authors include Uğur Şahin, Özlem Türeci, Sebastian Kreiter, Christoph Huber, Sebastian Boegel, Abderraouf Selmi, Martin Löwer, Jan Diekmann, Mathias Vormehr and Niels van de Roemer and has published in prestigious journals such as Nature, Science and Chemical Society Reviews.

In The Last Decade

Mustafa Diken

91 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mutant MHC class II epitopes drive therapeutic immune responses to cancer

2015 915 citations Sebastian Kreiter, Mathias Vormehr et al. Nature profile →
Exploiting the Mutanome for Tumor Vaccination

2012 617 citations John C. Castle, Sebastian Kreiter et al. Cancer Research profile →
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis

2021 324 citations LAURA D. KOLB, Thomas Bukur et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mustafa Diken Germany	34	3.0k	2.9k	2.0k	628	448	93	5.4k
Pedro Berraondo Spain	36	3.3k 1.1×	1.8k 0.6×	2.9k 1.4×	747 1.2×	463 1.0×	164	5.9k
Arthur E. Frankel United States	40	2.5k 0.8×	2.6k 0.9×	1.4k 0.7×	450 0.7×	464 1.0×	144	5.2k
Karine Breckpot Belgium	54	4.5k 1.5×	3.4k 1.2×	3.2k 1.6×	1.1k 1.8×	637 1.4×	170	7.6k
Sebastian Kreiter Germany	29	2.9k 1.0×	2.6k 0.9×	1.9k 1.0×	661 1.1×	214 0.5×	64	4.6k
Radek Špíšek Czechia	45	4.8k 1.6×	1.9k 0.6×	3.3k 1.7×	431 0.7×	829 1.9×	134	7.6k
Jim Xiang Canada	41	2.9k 0.9×	2.7k 0.9×	1.5k 0.8×	507 0.8×	386 0.9×	186	5.4k
Thorbald van Hall Netherlands	47	6.1k 2.0×	2.5k 0.9×	4.1k 2.0×	480 0.8×	500 1.1×	127	8.1k
Chrystal M. Paulos United States	39	5.5k 1.8×	2.3k 0.8×	5.4k 2.7×	1.1k 1.7×	795 1.8×	132	9.2k
Benjamin G. Vincent United States	34	3.0k 1.0×	1.7k 0.6×	2.6k 1.3×	255 0.4×	874 2.0×	104	5.3k
Jitka Fučíková Czechia	37	3.6k 1.2×	1.5k 0.5×	2.8k 1.4×	298 0.5×	767 1.7×	70	5.6k

Countries citing papers authored by Mustafa Diken

Since Specialization

Citations

This map shows the geographic impact of Mustafa Diken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mustafa Diken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mustafa Diken more than expected).

Fields of papers citing papers by Mustafa Diken

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mustafa Diken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mustafa Diken. The network helps show where Mustafa Diken may publish in the future.

Co-authorship network of co-authors of Mustafa Diken

This figure shows the co-authorship network connecting the top 25 collaborators of Mustafa Diken. A scholar is included among the top collaborators of Mustafa Diken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mustafa Diken. Mustafa Diken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Koning, Roman I., Melissa A. Graewert, Bert Wouters, et al.. (2024). On the Influence of Fabrication Methods and Materials for mRNA‐LNP Production: From Size and Morphology to Internal Structure and mRNA Delivery Performance In Vitro and In Vivo. Advanced Healthcare Materials. 13(26). e2401252–e2401252. 9 indexed citations

Schneider, Paul M., Michael Fichter, Federica De Lorenzi, et al.. (2024). A hepatocellular carcinoma model with and without parenchymal liver damage that integrates technical and pathophysiological advantages for therapy testing. Pharmacological Research. 211. 107560–107560. 2 indexed citations

Kranz, Lena M., David Eisel, Mustafa Diken, et al.. (2024). RNA-encoded Interleukin 2 with Extended Bioavailability Amplifies RNA Vaccine–Induced Antitumor T-cell Immunity. Cancer Immunology Research. 12(10). 1409–1420. 3 indexed citations

Schroer, Martin A., Daniel Franke, Thomas Nawroth, et al.. (2023). Polysarcosine-Functionalized mRNA Lipid Nanoparticles Tailored for Immunotherapy. Pharmaceutics. 15(8). 2068–2068. 23 indexed citations

Schneider, Paul M., Hua Zhang, Ömer Öztürk, et al.. (2023). In vivo gene silencing with novel siRNA loaded polypeptoide nanoparticles for anti-stromal therapy in hepatocellular carcinoma. Zeitschrift für Gastroenterologie. 61(8). e492–e493. 1 indexed citations

Salomon, Nadja, et al.. (2023). The landscape of T cell antigens for cancer immunotherapy. Nature Cancer. 4(7). 937–954. 67 indexed citations

KOLB, LAURA D., Thomas Bukur, Özlem Akilli‐Öztürk, et al.. (2021). A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis. Science. 371(6525). 145–153. 324 indexed citations breakdown →

Birtel, Matthias, Elham Masoumi, Leila Jafarzadeh, et al.. (2021). CRISPR/Cas9-mediated TGFβRII disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells in vitro. Journal of Translational Medicine. 19(1). 482–482. 27 indexed citations

Vormehr, Mathias, Sophie M. Lehar, Lena M. Kranz, et al.. (2020). Dexamethasone premedication suppresses vaccine-induced immune responses against cancer. OncoImmunology. 9(1). 1758004–1758004. 17 indexed citations

10.

Sun, Qingxue, Matthias Barz, Bruno G. De Geest, et al.. (2018). Nanomedicine and macroscale materials in immuno-oncology. Chemical Society Reviews. 48(1). 351–381. 130 indexed citations

11.

Frenzel, Katrin, Ludwig Heesen, Stefanie Bolte, et al.. (2017). Mutanome engineered RNA immuno-therapy (MERIT) for patients with triple negative breast cancer. Annals of Oncology. 28. xi29–xi29. 2 indexed citations

12.

Selmi, Abderraouf, Fulvia Vascotto, Kordula Kautz‐Neu, et al.. (2016). Uptake of synthetic naked RNA by skin-resident dendritic cells via macropinocytosis allows antigen expression and induction of T-cell responses in mice. Cancer Immunology Immunotherapy. 65(9). 1075–1083. 70 indexed citations

13.

Diken, Mustafa, et al.. (2015). Current Developments in Actively Personalized Cancer Vaccination with a Focus on RNA as the Drug Format. Progress in tumor research. 42. 44–54. 6 indexed citations

14.

Vormehr, Mathias, et al.. (2015). Mutanome directed cancer immunotherapy. Current Opinion in Immunology. 39. 14–22. 48 indexed citations

15.

Kreiter, Sebastian, Mathias Vormehr, Niels van de Roemer, et al.. (2015). Mutant MHC class II epitopes drive therapeutic immune responses to cancer. Nature. 520(7549). 692–696. 915 indexed citations breakdown →

16.

Castle, John C., Martin Löewer, Sebastian Boegel, et al.. (2014). Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma. BMC Genomics. 15(1). 190–190. 280 indexed citations

17.

Diken, Mustafa, Sebastian Kreiter, Fulvia Vascotto, et al.. (2013). mTOR Inhibition Improves Antitumor Effects of Vaccination with Antigen-Encoding RNA. Cancer Immunology Research. 1(6). 386–392. 39 indexed citations

18.

Castle, John C., Sebastian Kreiter, Jan Diekmann, et al.. (2012). Exploiting the Mutanome for Tumor Vaccination. Cancer Research. 72(5). 1081–1091. 617 indexed citations breakdown →

19.

Kreiter, Sebastian, Mustafa Diken, Abderraouf Selmi, et al.. (2011). FLT3 Ligand Enhances the Cancer Therapeutic Potency of Naked RNA Vaccines. Cancer Research. 71(19). 6132–6142. 62 indexed citations

20.

Kreiter, Sebastian, Abderraouf Selmi, Mustafa Diken, et al.. (2010). Intranodal Vaccination with Naked Antigen-Encoding RNA Elicits Potent Prophylactic and Therapeutic Antitumoral Immunity. Cancer Research. 70(22). 9031–9040. 248 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact